ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.46
arrow_downward
-1.98%(-0.090) 1D
Oct 6, 11:54:28 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.55
High
$4.58
Low
$4.45
Mkt. cap
183.08M
Avg. vol.
210.54K
Volume
25.07K
P/E ratio
1.08
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
Open
$4.55
High
$4.58
Low
$4.45
Mkt. cap
183.08M
Avg. vol.
210.54K
Volume
25.07K
P/E ratio
1.08
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
StreetInsider
·
17 minutes ago
Paramount Skydance seals $110B Warner Bros deal as combined company hits NYSE
Seeking Alpha
·
58 minutes ago
25 stocks up more than +100% in 2026 as the S&P 500 hits record high
MarketWatch
·
7 minutes ago
These 5 chip stocks are cheaper than the S&P 500 — and offer faster growth
NBC News
·
1 hour ago
S&P 500 hits record high as Nvidia nears $6 trillion milestone
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.